Oxidized lipoproteins may be important in the pathogenesis of atherosclerosis. Because diabetic subjects are particularly prone to vascular disease, and glucose autoxidation and protein glycation generate reactive oxygen species, we explored the role of glucose in lipoprotein oxidation. Glucose enhanced low density lipoprotein (LDL) oxidation at concentrations seen in the diabetic state. Conjugated dienes, thiobarbituric acid reactive substances, electrophoretic mobility, and degradation by macrophages were increased when LDL was modified in the presence of glucose. In contrast, free lysine groups and fibroblast degradation were reduced. Although loss of reactive lysine groups could be due to either oxidative modification or nonenzymatic glycation of apolipoprotein B-100, inhibition of lipid peroxidation by the metal chelator, diethylenetriamine pentaacetic acid, blocked the changes in free lysines. Thus, glycation of lysine residues is unlikely to account for the alterations in macrophage and fibroblast uptake of LDL modified in the presence of glucose. Glucose-mediated enhancement of LDL oxidation was partially blocked by superoxide dismutase and nearly completely inhibited by butylated hydroxytoluene. These findings indicate that glucose enhances LDL lipid peroxidation by an oxidative pathway involving superoxide and raise the possibility that the chronic hyperglycemia of diabetes accelerates lipoprotein oxidation, thereby promoting diabetic vascular disease. (J. Clin. Invest. 1994. 94:771-778.)
Introduction
Atherosclerosis is a leading cause of morbidity and mortality in patients suffering from diabetes mellitus. Although other disorders associated with vascular disease, such as hypertension, central obesity, and hyperlipidemia, frequently coexist with the diabetic state (1) , they appear inadequate to explain the increased risk of atherosclerosis. These observations suggest that additional factors may be involved in the accelerated macrovascular disease of diabetes.
Epidemiological, clinical, and genetic investigations indicate that elevated levels of low density lipoprotein (LDL) are another important risk factor for coronary artery disease. Although LDL levels are frequently normal in diabetic patients, hyperlgycemic or other metabolic alterations secondary to the diabetic state may alter lipoproteins to a form that promotes atherogenesis. One such modification may be the nonenzymatic glycation of LDL which has been shown in some (2) , but not all, studies (3) to be taken up rapidly by macrophages in culture. The unregulated uptake of modified lipoproteins by macrophages is likely to play a pivotal role in cholesterol accumulation, a key early event in lesion formation. Autoantibodies against glycated LDL (4) also might result in the formation of immune complexes, which have been postulated to stimulate macrophage foam cell formation (5) . Recently, there has been considerable interest in oxidized LDL, another modification of lipoproteins that may play an important role in atherogenesis (6, 7) . LDL can be oxidatively damaged in vitro by endothelial cells, monocyte-macrophages, and arterial smooth muscle cells (for review see reference 7). Lipoxygenases may be involved in the oxidative modification of LDL by endothelial cells and macrophages (7, 8) , whereas superoxide plays an important role in LDL oxidation by arterial smooth muscle cells and activated monocytes (9, 10) . Oxidized LDL is thought to promote atherogenesis by a multitude of different mechanisms (7, 1 1 ) .
Indirect evidence suggests that lipoprotein oxidation may be increased in diabetes. First, increased levels of thiobarbituric acid reactive substances (TBARS)' have been demonstrated in plasma from diabetic subjects (12) . Although TBARS increase during oxidative modification of lipoproteins, their presence in plasma is not specific for products of lipid peroxidation. Second, plasma lipoproteins isolated from diabetic rats have increased TBARS and are cytotoxic to cultured cells ( 13 ) , which suggests that they may have been oxidatively modified in vivo. Both lipoprotein TBARS content and cytotoxicity were reduced either by antioxidants or by treatment of hyperglycemia with insulin (13) . Finally, glucose autoxidation (14, 15) and nonenzymatic protein glycation (15, 16) can result in the generation of oxygen-free radicals, such as superoxide, which stimulate lipoprotein oxidation (9, 10) . Indeed, a recent study has suggested that LDL lipid peroxidation is enhanced by high concentrations of glucose ( 17) .
In the current studies we have explored the relationships between elevated levels of glucose, the hallmark of the diabetic state, and the oxidative modification of LDL. We show that glucose promotes lipoprotein oxidation by a pathway that involves superoxide. Human monocyte-derived macrophages rap- CuS04 (m). The changes in conjugated dienes ( Fig. 1 a) , lipid peroxides ( Fig. 1 b) , TBARS ( Fig. 1 c) , and relative LDL electrophoretic mobility ( Fig. 1 d) Cells. Human monocyte-derived macrophages were isolated by density gradient centrifugation by the method of Boyum (25). The mononuclear cell band was washed twice at 40C in RPMI 1640 medium and then plated at 3 x 105 cells/16-mm well at 370C in 5% C02/95% air in the same medium containing 20% (vol/vol) autologous serum, 100 U/ml penicillin, 100 ug/ml streptomycin, and 2 mM glutamine (26) . Monocyte-derived macrophages were fed twice weekly and used within 7-10 d of plating. Human skin fibroblasts were cultured from punch biopsies from the medial thigh of normal volunteers as described previously (26) . Subcultures were used between passages 4 and 12. The cells were plated at 7 x 104 cells/35-mm dish at 370C in 5% C02/95% air in DME supplemented with 10% calf serum, 100 U/ml penicillin, and 100 jig/ml streptomycin. After 5 d in culture, the medium of the cells was changed to DME supplemented with 10% lipoprotein-deficient human serum (prepared by ultracentrifugation at d = 1.25 g/ml) and used after 48 h of incubation.
Metabolism of lipoproteins by cells. Before incubation with fibroblasts and macrophages, '25I-labeled lipoproteins were dialyzed against 150 mM NaCl with 50 jiM DTPA (pH 7.4) to remove the reaction mixture used for modification. Uptake and degradation of the '251I-labeled lipoprotein ( 150-250 cpm/ng protein) were assessed after a 5-h incubation with cells at 37'C. LDL degradation products in the incubation medium were assayed by measurement of trichloroacetic acid-soluble (noniodide) radioactivity (26) . Cell-free LDL degradation, which represented < 5% of total radioactivity, was subtracted from total degradation. For measurement of protein, the cell layer was washed three times with phosphate-buffered saline at the end of the incubation and extracted by incubation at room temperature with 0.5 ml of 0.1 N NaOH for 1 h. Other assays. Protein was measured by the method of Lowry et al. (27) using bovine serum albumin as the standard. Free protein amino groups in LDL were estimated using TNBS. LDL (50 ,ug of protein) was mixed with 1 ml of 4% NaHCO3 (pH 8.4) and 50 Ml of 0.1% TNBS and heated for 1 h at 370C after which the absorbance at 340 nm was measured (28) . LDL electrophoresis was carried out, at pH 8.6, in barbital buffer on 0.5% agarose gel as described (26) ; electrophoretic mobility was expressed relative to native LDL. The specific activities of SOD and catalase were 5.4 (29) and 58 U/,ug (30) , respectively.
Results
LDL incubated for 48 h in phosphate-buffered saline supplemented with 1 AM EDTA underwent little modification as monitored by changes in conjugated dienes, lipid peroxides, TBARS, and electrophoretic mobility (Fig. 1) . Addition of glucose to the incubation medium led to accelerated LDL oxidation in the presence of copper. All measures of lipoprotein oxidation, including conjugated dienes (Fig. 1 a) , lipid peroxides ( Fig. 1  b) , TBARS (Fig. 1 c) , and electrophoretic mobility (Fig. 1 d) , initially increased in a time-dependent fashion in the presence of 25 mM glucose. Lipid peroxides and TBARS content reached a maximum and then fell during the 48-h incubation, whereas conjugated dienes and electrophoretic mobility increased and then remained constant. The effect of glucose on lipoprotein oxidation was concentration dependent (Fig. 2) . The major increase in the oxidative modification of LDL, assessed as conjugated dienes (Fig. 2 a) , lipid peroxides (Fig. 2 b) , and TBARS (Fig. 2 c) (Fig. 3 ). This range of glucose concentrations is similar to that observed in diabetic patients, suggesting that LDL experiencing prolonged hyperglycemia in vivo might undergo accelerated oxidative modification.
To determine whether the glucose-induced changes in the oxidative modification of LDL were due to oxidative modification or protein glycation, experiments were performed in which lipid peroxidation was blocked by the transition metal chelator, DTPA. The extent of lipoprotein modification was determined by measurement of TBARS, which measures soluble bifunctional aldehydes derived from lipid peroxidation, and of TNBS reactivity, which measures free amine groups on protein-associated lysyl residues. In the presence of both glucose and copper, but in the absence of DTPA, TBARS progressively increased (Fig. 4 a) while TNBS reactivity progressively decreased (Fig.  4 b) . Similar results were observed when LDL was incubated with either glucose or copper alone, or together (Fig. 4) . These findings could reflect derivatization of protein amino groups by either lipid peroxidation products or by nonenzymatic glycation. When the same experiment was performed in the presence of DTPA, which inhibits lipid peroxidation, no changes were observed in either TBARS (Fig. 4 c) or TNBS reactivity (Fig. 4  d) . Because glycation is largely independent of transition metal ions, these results suggest that modification of apolipoprotein B-100 was due to oxidation. In the absence of DTPA, the TBARS content of LDL demonstrated an inverse linear relationship with TNBS reactivity (Fig. 5) , providing further evidence that protein amino groups were reacting with lipid oxidation products.
To determine the mechanisms) by which glucose facilitates the oxidative modification of LDL, we studied the effect of several scavengers of reactive oxygen species. Stimulation of lipid peroxidation by glucose in the presence of added copper (0.5 [SM) was partially inhibited either by SOD (30 ,[g/ml), which catalyzes the breakdown of superoxide, or by catalase (50 [Sg/ml), which catalyzes the breakdown of hydrogen peroxide (Fig. 6 d) . The effect of these enzymes on the inhibition of LDL oxidation was additive. Heat inactivation of either SOD or catalase eliminated their inhibitory activity (data not shown). BHT markedly inhibited glucose-mediated LDL oxidation. SOD and catalase together almost completely inhibited LDL oxidation in the presence of either glucose (Fig. 6 b) or copper alone (Fig. 6 c) . Taken together, these results indicate that the glucose-and copper-induced lipid peroxidation of LDL is likely to be dependent on a reaction pathway that requires superoxide and hydrogen peroxide.
To explore the possible role of superoxide and hydrogen peroxide in glucose-stimulated oxidation, similar studies were performed with LDL incubated for 120 h with 15 mM glucose in the absence of added copper. As with glucose and copper together, SOD partially prevented LDL oxidation, measured as the increase in conjugated dienes, lipid peroxides, and TBARS (Table I Figure 3 . Glucose-stimulated LDL oxidation in the absence of copper. LDL was exposed to the indicated final concentration of glucose as described in Fig. 2 except that copper was omitted from the reaction mixture. After a 72-h incubation, the medium content of conjugated dienes (Fig. 3 a) , lipid peroxides (Fig.  3 b) , and TBARS (Fig. 3 c) We next investigated the cellular metabolism of the modified lipoproteins using cultured human monocyte-derived macrophages and skin fibroblasts. The uptake and degradation of modified '25I-LDL by macrophages increased in parallel with the increase in lipid peroxidation (Fig. 7 a) . In contrast, the rates of degradation of these lipoproteins by fibroblasts occurred in the reverse order: LDL was degraded most rapidly, acetylated LDL was degraded least rapidly, while the oxidatively modified forms of LDL were degraded at intermediate rates (Fig. 7 b) . The free protein amino content of the lipoproteins showed an inverse correlation with the rate of degradation of these lipoproteins by macrophages (Fig. 8 a) and a positive correlation with the rate of degradation by skin fibroblasts (Fig. 8 b) . Human macrophages exhibit numerous scavenger receptors but are relatively poor in LDL-receptor activity, while fibroblasts are rich in LDL receptors but lack scavenger receptor activity (33) . 
Discussion
These studies demonstrate that physiologically relevant concentrations of glucose enhance the oxidation of LDL in a cell-free system. Although the addition of glucose alone led to increased LDL oxidation, this effect was magnified in the presence of low concentrations of copper, a transition metal that is redoxactive and catalyzes lipid peroxidation (34, 35) . The effect of glucose on LDL oxidation was most pronounced at glucose concentrations that span the range seen in the diabetic state.
To determine the mechanism(s) whereby glucose stimulated LDL lipid peroxidation, several inhibitors of reactive oxygen species were tested. LDL oxidation by glucose in the absence of added metal ions was inhibited by SOD but not by catalase. The exact mechanism for the acceleration of LDL lipid peroxidation by glucose is unknown but is likely to involve superoxide TNBS d plus DTPA and CuSO4 simultaneously (v) for the indicated times, in the absence (Fig. 4, a and b) or presence (Fig. 4, c and d) anion. Since catalase was not inhibitory, either the reaction does not involve hydrogen peroxide or the oxidant is generated at a sequestered site that is inaccessible to catalase. LDL oxidation was also inhibited by DTPA, a metal chelator, indicating that transition metal ions are likely to play a role. Low .0 .4 < 0.01r 0 metal ions may be endogenously bound to LDL (36) and are ubiquitously present in the buffers used for biochemical studies (34) . It is noteworthy that low levels of protein-bound metal ions have been implicated in the oxidative damage of tissue during aging (37) and that products generated by metal-catalyzed glycoxidation reactions accumulate in the proteins of diabetic patients (15) . Thus, protein-bound metal ions may catalyze oxidation reactions in vivo. The pathway for LDL oxidation was apparently different when both glucose and copper were present in the reaction mixture. Under these conditions, LDL oxidation was partially inhibited by either SOD or catalase, and the enzymes together completely blocked lipid peroxidation. Thus, both superoxide and hydrogen peroxide appear to play a role in the stimulation of LDL oxidation by glucose together with copper. One potential mechanism consistent with these observations is generation of hydroxyl radicals (HO') by superoxide-driven Haber-Weiss chemistry (Eq. 1-3) (35) Figure 6 . Effect of inhibitors of oxidation on glucose-and copper-mediated modification of LDL. LDL was incubated with no addition (Fig. 6 a) , with glucose (25 mM) alone (Fig.   6 b), CuSO4 (0.5 IM) alone (Fig. 6 c) , and glucose and CuSO4 (Fig. 6 d) Derivatization of lysine e-amine residue on apolipoprotein B-100 alters the receptor recognition of LDL and thereby controls its uptake and degradation by cells (33, 43) . When lysine residues are modified by acetylation or by reaction with malondialdehyde, LDL becomes a ligand for the scavenger receptor on macrophages but loses recognition by the LDL receptor on human fibroblasts (33, 43) . Derivatization of lysine amines by reactive aldehydes generated during lipid peroxidation may likewise be important in mediating the binding of oxidatively modified LDL to the scavenger receptor (44). Similar reactions might cause LDL modified in the presence of glucose to gain scavenger receptor recognition. Alternatively, nonenzymatic protein glycation may alter cell-surface recognition of the modified lipoprotein (2) (3) (4) . To investigate the relative contributions of these pathways to alterations in apolipoprotein B-100 of modified LDL in the presence of glucose, we monitored the reactivity of protein amino groups with TNBS. This reagent predominantly reacts with free amines on lysines that are accessible to the aqueous phase (28) . When LDL was incubated with glucose and copper, over 50% of TNBS reactivity was lost. The decrease in reactive amino groups was associated with an increase in lipid peroxidation products as measured by TBARS. Inclusion of DTPA, which chelates the metal ions necessary for propagation of lipid peroxidation in a redox inactive form (9) , blocked both loss of TNBS reactivity and formation of TBARS. Although the slow process of nonenzymatic protein glycation can be inhibited slightly by metal ion chelation (45), we observed complete inhibition both of loss of TNBS reactivity and of increase in lipid peroxidation in the presence of DTPA. This observation strongly suggests that loss of free amino groups is likely to reflect oxidative damage to apolipoprotein B-100 by a glucose-dependent mechanism. However, we cannot exclude the possibility that nonenzymatic glycation of LDL, below the level of detection of the TNBS assay, contributed to the oxidative modification by generating reactive oxygen species.
The cellular metabolism of glucose-modified LDL was examined using cultured human skin fibroblasts and human monocyte-derived macrophages. Uptake of the modified LDL by fibroblasts decreased with increasing oxidative modification. The uptake and degradation of LDL oxidized in the presence of both glucose and copper by fibroblasts were considerably inhibited relative to unmodified LDL, consistent with decreased recogni- Figure 7 . Degradation of modified lipoproteins by cultured human monocyte-derived macrophages (Fig. 7 a) and human skin fibroblasts (Fig. 7 b) (Fig. 7 a) or skin V fibroblasts (Fig. 7 b) tion of the modified lipoprotein by the LDL receptor (33, 43, 46) . Degradation by fibroblasts of LDL modified in the presence of glucose or copper alone was inversely proportional to the extent of modification as assessed by TBARS and TNBS reactivity. In contrast, the uptake of the modified LDL by human monocyte-derived macrophages was enhanced with increasing oxidative modification. The extent of degradation by both fibroblasts and macrophages was related to the degree of lysine derivatization of apolipoprotein B-I00. As the number of lysines reactive with TNBS decreased in macrophages, uptake and degradation increased, while fibroblasts internalized and degraded the modified lipoprotein less efficiently. These findings are consistent with uptake of the modified LDL by the macrophage scavenger receptor(s) (33) and suggest that modification of LDL induced by chronic hyperglycemia might be an important contributing factor in accelerating foam cell formation in diabetes. Oxidized LDL has been shown to affect multiple events that might be involved in atherogenesis (11) , including monocyte chemotaxis (7), cytotoxicity (47), cytokine and growth factor production (48, 49), endothelium-derived relaxing factor-mediated vascular reactivity (50) , and foam cell formation (7, 9, 26, 34) . If chronic hyperglycemia facilitates these events by promoting lipoprotein oxidation, this may explain in part the vascular disease observed in diabetes. Further studies are required to firmly establish whether lipoprotein oxidation is increased in patients suffering from diabetes, since these processes might be amenable to antioxidant therapy. Such antioxidants may prove to be important in preventing the markedly increased incidence of atherosclerotic complications in this common and debilitating disease.
